Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Glioblastoma 9Central Nervous System Neoplasms 6Brain Neoplasms 6Oligodendroglioma 3Gliosarcoma 3Astrocytoma 3Sarcoma 2Optic Nerve Glioma 2Neoplasm Metastasis 2Glioma 2Ependymoma 2Zollinger-Ellison Syndrome 1Wilms Tumor 1Vipoma 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prolactinoma 1Pituitary Neoplasms 1Pheochromocytoma 1Ovarian Neoplasms 1Osteosarcoma 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Neuroectodermal Tumors 1Neuroblastoma 1Multiple Endocrine Neoplasia Type 2b 1

Interventions

Tegafur 2Leucovorin 2Immunoenzyme Techniques 2vandetanib 1temsirolimus 1soblidotin 1Temozolomide 1Polymerase Chain Reaction 1Paclitaxel 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Immunization, Passive 1Gemcitabine 1Etoposide 1Drug Therapy 1Antibodies, Monoclonal 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Unspecified Adult Solid Tumor, Protocol Specific × Temozolomide × Clear all
NCT00601614 2014-03-10

Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Mayo Clinic

Phase 1 Withdrawn
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡